Dow Up0.07% Nasdaq Up0.61%

Repros Therapeutics Inc. (RPRX)

-NasdaqCM
9.02 Up 0.27(3.09%) Nov 26, 4:00PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue -   -   -  
Cost of Revenue -   -   -  
Gross Profit -   -   -  
Operating Expenses
Research Development22,912  13,343  8,682  
Selling General and Administrative4,818  4,827  3,811  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (27,730) (18,170) (12,493)
Income from Continuing Operations
Total Other Income/Expenses Net9  3  2  
Earnings Before Interest And Taxes(27,721)(18,167)(12,491)
Interest Expense -   -   -  
Income Before Tax(27,721)(18,167)(12,491)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(27,721)(18,167)(12,491)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (27,721) (18,167) (12,491)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (27,721) (18,167) (12,491)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.